Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Anticoagulation therapy in animal research

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Silvis, S.M., Middeldorp, S., Zuurbier, S.M., Cannegieter, S.C. & Coutinho, J.M. Risk factors for cerebral venous thrombosis. Semin. Thromb. Hemost. 42, 622–631 (2016).

    Article  Google Scholar 

  2. 2

    Barakat, A.F. et al. Initial experience with high-risk patients excluded from clinical trials: safety of short-term anticoagulation after left atrial appendage closure device. Circ Arrhythm Electrophysiol 9, e004004 (2016).

    CAS  Article  Google Scholar 

  3. 3

    Liu, Z. et al. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study. BMC Musculoskelet. Disord. 17, 76 (2016).

    Article  Google Scholar 

  4. 4

    Moeinipour, A. et al. The best anticoagulation therapy in multiple-trauma patients with mechanical heart valves: evaluation of latest guidelines and studies. Heart Surg. Forum 18, E271–E274 (2015).

    Article  Google Scholar 

  5. 5

    Montravers, P. et al. Therapeutic management of peritonitis: a comprehensive guide for intensivists. Intensive Care Med. 42, 1234–1247 (2016).

    CAS  Article  Google Scholar 

  6. 6

    Schulman, S. & Majeed, A. A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopedic surgery. Drug Saf. 34, 449–463 (2011).

    CAS  Article  Google Scholar 

  7. 7

    Cornell University College of Veterinary Medicine. Comparative coagulation heparin site. Accessed on September 1, 2016.

  8. 8

    Llano, R. et al. Vascular responses to drug-eluting and bare metal stents in diabetic/hypercholesterolemic and nonatherosclerotic porcine coronary arteries. Circ. Cardiovasc. Interv. 4, 438–446 (2011).

    CAS  Article  Google Scholar 

  9. 9

    Plumb, D.C. Plumb Veterinary Drug Handbook. (Wiley-Blackwell, Ames, IA, 2015).

    Google Scholar 

  10. 10

    Sasaki, T., Tsuda, S., Trujillo, M., Riemer, K. & Reinhartz, O. Maintenance dose of warfarin in sheep and effect of diet; a preliminary report. J. Invest. Surg. 25, 29–32 (2012).

    Article  Google Scholar 

  11. 11

    Byrom, M.J., Bannon, P.G., White, G.H. & Martin, K.C. Animal models for the assessment of novel vascular conduits. J. Vasc. Surg. 52, 176–95 (2010).

    Article  Google Scholar 

  12. 12

    Brakmann, K., Spriestersbach, H., Berger, F. & Schmitt, B. Administration of Dalteparin in sheep for cardiac interventions. Int. Card. J. 1, 1–7 (2015).

    Google Scholar 

  13. 13

    Wu, G., Lin, C. & Qu, W. Initial in vivo evaluation of a novel left ventricular assist device. BioMed Res. Int. (2015).

Download references

Author information



Corresponding author

Correspondence to Victoria Hampshire.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hampshire, V. Anticoagulation therapy in animal research. Lab Anim 45, 431–432 (2016).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing